
    
      -  A prospective, non-randomized trial

        -  Study population: 15 patients

        -  Clinical follow up will be required at postoperative, 1 month, 6 months, 1 year, 2
           years, 3 years, 4 years, 5 years;

        -  All the subjects perform the angiography, Intra-vascular ultrasound (IVUS) and Optical
           coherence tomography (OCT) at 1 year and 3 years.

        -  The primary study endpoint is target lesion failure (TLF) at 1 month post procedure; and
           imaging findings as the secondary study endpoint. To evaluate the feasibility, safety
           and performance of IBS.
    
  